Cyclosporine treatment of anal furunculosis in 26 dogs

被引:34
作者
Hardie, RJ
Gregory, SP
Tomlin, J
Sturgeon, C
Lipscomb, V
Ladlow, J
机构
[1] Univ Wisconsin, Sch Vet Med, Dept Surg Sci, Madison, WI 53706 USA
[2] Queen Mothers Hosp Anim, Univ London Royal Vet Coll, Hatfield AL9 7TA, Herts, England
关键词
D O I
10.1111/j.1748-5827.2005.tb00267.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
OBJECTIVES: To evaluate the effect of cyclosporine on anal furunculosis lesions in 26 dogs. METHODS: Lesions were graded as mild in 11 dogs, moderate in eight and severe in seven. Each dog was treated with approximately 4 mg/kg cyclosporine orally every 12 hours until the lesions resolved or showed no further improvement. Residual lesions were resected surgically. RESULTS: Eighteen dogs (69 per cent) experienced complete resolution, seven (27 per cent) improved but had residual lesions and one (4 per cent) showed no improvement. The mean duration of treatment until resolution or no further improvement was 8.8 weeks (range four to 24 weeks). Nine dogs (35 per cent) experienced recurrence. Six were from the group that had shown complete resolution and three were from the group that had surgery. Fifteen dogs (58 per cent) developed side effects to cyclosporine, although none required treatment to be discontinued. Mean duration of follow-up was 6.8 months (range one to 20 months). CLINICAL SIGNIFICANCE: Cyclosporine was effective at resolving or reducing anal furunculosis lesions in 25 of 26 dogs (96 per cent). However, residual or recurrent lesions remain a potential problem, and surgical resection or long-term cyclosporine treatment may be necessary in some dogs.
引用
收藏
页码:3 / 9
页数:7
相关论文
共 57 条
[31]  
MATUSHEK KJ, 1991, COMP CONT EDUC PRACT, V13, P621
[32]   Cyclosporin and ketoconazole interaction for treatment of perianal fistulas in the dog [J].
Mouatt, JG .
AUSTRALIAN VETERINARY JOURNAL, 2002, 80 (04) :207-211
[33]   CYCLOSPORINE - A REVIEW OF THE PHARMACOKINETIC PROPERTIES, CLINICAL EFFICACY AND TOLERABILITY OF A MICROEMULSION-BASED FORMULATION (NEORAL) [J].
NOBLE, S ;
MARKHAM, A .
DRUGS, 1995, 50 (05) :924-941
[34]  
Okubo Tetsuyuki, 1993, Hokkaido Journal of Medical Science, V68, P665
[35]   SIDE-EFFECTS OF SYSTEMIC CYCLOSPORINE IN PATIENTS NOT UNDERGOING TRANSPLANTATION [J].
PALESTINE, AG ;
NUSSENBLATT, RB ;
CHAN, CC .
AMERICAN JOURNAL OF MEDICINE, 1984, 77 (04) :652-656
[36]   SEVERE NEUROLOGIC TOXICITY INDUCED BY CYCLOSPORINE-A IN 3 RENAL-TRANSPLANT PATIENTS [J].
PALMER, BF ;
TOTO, RD .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 18 (01) :116-121
[37]   Role of cytokines in the pathogenesis of inflammatory bowel disease [J].
Papadakis, KA ;
Targan, SR .
ANNUAL REVIEW OF MEDICINE, 2000, 51 :289-298
[38]   Cyclosporine and ketoconazole for the treatment of perianal fistulas in dogs [J].
Patricelli, AJ ;
Hardie, RJ ;
McAnulty, JE .
JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2002, 220 (07) :1009-1016
[39]  
PAUS R, 1989, LAB INVEST, V60, P305
[40]  
Petri JB, 1998, EUR J DERMATOL, V8, P104